Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
7 Small-Cap Stocks to Buy in July 2022
08:15am, Monday, 04'th Jul 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.
Why Dynavax Crushed the Market on Thursday
05:04pm, Thursday, 23'rd Jun 2022
Its partner's coronavirus vaccine comes one important step closer to approval in Europe.
4 Small Caps for Growth-Focused Investors
02:19pm, Thursday, 09'th Jun 2022
Investors seeking opportunities among growth stocks could be interested in the following small caps as they represent companies whose trailing 12-month net income per share has improved significantly
Dynavax: Evolving Endemic Situation Adds To Its Risk
11:59am, Monday, 23'rd May 2022
DVAX will do well as long as the coronavirus vaccine demand exists. While the urgency is somewhat abated, an evolving endemic situation may continue to need CpG 1018.
Dynavax (DVAX) Up as EMA Accepts Valneva's COVID-19 Vaccine MAA
02:17pm, Friday, 20'th May 2022
Dynavax (DVAX) gains as the EMA accepts partner Valneva's MAA for COVID-19 vaccine.
Why Dynavax Stock Blasted 16% Higher Today
06:01pm, Thursday, 19'th May 2022
One of its vaccine partners had some encouraging regulatory news to report.
Why Dynavax Stock Won on a Losing Monday for the Market
06:46pm, Monday, 16'th May 2022
The company earns an Emergency Use Authorization from a well-off Middle Eastern country.
Dynavax to Present at the H.C. Wainwright Global Investment Conference
04:10pm, Monday, 16'th May 2022
EMERYVILLE, Calif. , May 16, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, toda
Dynavax Technologies (DVAX) Misses Q1 Earnings and Revenue Estimates
07:34pm, Thursday, 05'th May 2022
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -8.33% and 3.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clover To Present at World Vaccine Congress Washington 2022
06:30am, Tuesday, 12'th Apr 2022
SHANGHAI, China, April 12, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeu
Why Dynavax Stock Was Winning This Week
01:20pm, Friday, 18'th Mar 2022 The Motley Fool
Several coronavirus vaccines using the company's adjuvant are advancing up the regulatory ladder.
Why Dynavax Stock Was Winning This Week
09:20am, Friday, 18'th Mar 2022
Several coronavirus vaccines using the company's adjuvant are advancing up the regulatory ladder.
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
11:53am, Thursday, 17'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis
AbbVie, Inc. (NYSE: ABBV) announced
Why BioNTech, Dynavax, Novavax, and Pfizer Stocks Are Jumping Today
04:24pm, Monday, 14'th Mar 2022 The Motley Fool
The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.
Why BioNTech, Dynavax, Novavax, and Pfizer Stocks Are Jumping Today
12:24pm, Monday, 14'th Mar 2022
The broader stock market bounce and news from China are fueling gains for all four vaccine stocks.
